feed,title,long_url,short_url
Benzinga,Chimerix's CMX521 Antiviral Program Shows Potential Against COVID-19 In Preclinical Studies,https://benzinga.com/general/biotech/22/02/25810194/chimerixs-cmx521-antiviral-program-shows-potential-against-covid-19-in-preclinical-studies,https://bit.ly/3pfb3aW
